Robert W. Georgantas
Presidente presso Providence Therapeutics, Inc.
Patrimonio netto: 48 150 $ in data 30/04/2024
Profilo
Robert W.
Georgantas is currently the President & Chief Technology Officer at Providence Therapeutics, Inc. Prior to this, he was the Senior VP-Research & Translational Science at Biodesix, Inc. He holds a doctorate degree from The Johns Hopkins University School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BIODESIX, INC.
0.03% | 21/11/2022 | 38 214 ( 0.03% ) | 48 150 $ | 30/04/2024 |
Posizioni attive di Robert W. Georgantas
| Società | Posizione | Inizio |
|---|---|---|
Providence Therapeutics, Inc.
 Providence Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Providence Therapeutics, Inc. operates as biotechnology company. The company is headquartered in Calgary, Canada. | Presidente | 01/02/2023 |
Precedenti posizioni note di Robert W. Georgantas
| Società | Posizione | Fine |
|---|---|---|
| BIODESIX, INC. | Corporate Officer/Principal | 01/02/2023 |
Formazione di Robert W. Georgantas
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIODESIX, INC. | Health Services |
| Aziende private | 1 |
|---|---|
Providence Therapeutics, Inc.
Providence Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Providence Therapeutics, Inc. operates as biotechnology company. The company is headquartered in Calgary, Canada. | Health Technology |
- Borsa valori
- Insiders
- Robert W. Georgantas
